Etoricoxib-induced acute generalized exanthematous pustulosis.
Mäkelä
Leeni
L
Lammintausta
Kaija
K
D000208:Acute Disease; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000473:pathology; D000077613:Etoricoxib; D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010328:Patch Tests; D011725:Pyridines / Q000009:adverse effects*; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000473:pathology; D013450:Sulfones / Q000009:adverse effects*
D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib